LORAZEPAM

LORAZEPAM was reported 180753 times

LORAZEPAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 154 0.6725
1 DEEP VEIN THROMBOSIS POSTOPERATIVE 825 0.4119
2 LUPUS VULGARIS 517 0.4103
3 C-REACTIVE PROTEIN 349 0.3765
4 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 195 0.3476
5 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 608 0.2932
6 X-RAY ABNORMAL 510 0.2849
7 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 188 0.2814
8 SWOLLEN JOINT COUNT INCREASED 827 0.2591
9 DISLOCATION OF VERTEBRA 587 0.2571
10 FACET JOINT SYNDROME 765 0.2347
11 RHEUMATIC FEVER 951 0.2131
12 RETINITIS 366 0.2117
13 PERIPHERAL VENOUS DISEASE 802 0.1962
14 PORPHYRIA ACUTE 280 0.1951
15 DUODENAL ULCER PERFORATION 1439 0.1933
16 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1373 0.1914
17 RHEUMATOID FACTOR POSITIVE 1065 0.1842
18 MUSCLE INJURY 1381 0.1665
19 CATATONIA 874 0.1663
20 HELICOBACTER INFECTION 1578 0.1534
21 C-REACTIVE PROTEIN ABNORMAL 939 0.1462
22 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 923 0.1420
23 FOLLICULITIS 1388 0.1322
24 PEMPHIGUS 1647 0.1316
25 SOFT TISSUE DISORDER 144 0.1298
26 SOPOR 1626 0.1226
27 HAND DEFORMITY 1493 0.1137
28 LIP DRY 1024 0.1126
29 NEUROLEPTIC MALIGNANT SYNDROME 1321 0.1113
30 BONE EROSION 371 0.1048
31 PERICARDITIS 1695 0.1008
32 BREAST CANCER STAGE III 647 0.0998
33 HYPERCHOLESTEROLAEMIA 909 0.0941
34 AUTOIMMUNE DISORDER 899 0.0921
35 BURSITIS 1119 0.0921
36 SYNOVITIS 1639 0.0908
37 DRUG TOLERANCE DECREASED 255 0.0907
38 JOINT RANGE OF MOTION DECREASED 1187 0.0884
39 WOUND INFECTION 947 0.0864
40 OBESITY 1331 0.0835
41 SEDATION COMPLICATION 212 0.0830
42 MULTIPLE DRUG OVERDOSE INTENTIONAL 256 0.0795
43 FIBROMYALGIA 1886 0.0775
44 GLOSSODYNIA 1695 0.0756
45 IRRITABLE BOWEL SYNDROME 1617 0.0753
46 NEPHROGENIC ANAEMIA 338 0.0729
47 BRADYPHRENIA 475 0.0727
48 PNEUMONIA VIRAL 219 0.0686
49 HYPERPARATHYROIDISM SECONDARY 172 0.0686
50 DELIRIUM 2376 0.0684
51 TYPE 2 DIABETES MELLITUS 2282 0.0677
52 BLOOD PRESSURE SYSTOLIC ABNORMAL 167 0.0675
53 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 149 0.0666
54 DEREALISATION 142 0.0660
55 PSYCHOMOTOR RETARDATION 184 0.0654
56 GRIP STRENGTH DECREASED 572 0.0649
57 WOUND 1787 0.0639
58 EXOSTOSIS 580 0.0635
59 MATERNAL EXPOSURE TIMING UNSPECIFIED 237 0.0630
60 LIVER INJURY 1505 0.0613
61 SEROTONIN SYNDROME 1176 0.0612
62 BLOOD PRESSURE DIASTOLIC ABNORMAL 154 0.0605
63 LIVE BIRTH 498 0.0595
64 STUPOR 189 0.0588
65 PUSTULAR PSORIASIS 201 0.0585
66 RESPIRATORY DEPRESSION 717 0.0584
67 MULTIPLE-DRUG RESISTANCE 181 0.0583
68 ATELECTASIS 562 0.0581
69 BLEPHAROSPASM 365 0.0579
70 APLASTIC ANAEMIA 298 0.0570
71 SEDATION 1469 0.0560
72 SCIATICA 887 0.0556
73 LOWER LIMB FRACTURE 1063 0.0553
74 SUBSTANCE ABUSE 450 0.0552
75 COMA SCALE ABNORMAL 158 0.0545
76 MAJOR DEPRESSION 398 0.0544
77 PARKINSONISM 528 0.0541
78 SELF INJURIOUS BEHAVIOUR 162 0.0530
79 BRADYKINESIA 311 0.0526
80 WALKING AID USER 347 0.0526
81 IMPAIRED HEALING 1726 0.0525
82 SCHIZOPHRENIA 637 0.0524
83 PRESCRIBED OVERDOSE 1010 0.0521
84 STATUS EPILEPTICUS 587 0.0519
85 DIABETIC NEUROPATHY 254 0.0513
86 MUSCLE RIGIDITY 608 0.0508
87 ULCER HAEMORRHAGE 343 0.0506
88 HYPERREFLEXIA 176 0.0505
89 PSYCHOTIC DISORDER 1473 0.0498
90 INTENTIONAL SELF-INJURY 1005 0.0497
91 PNEUMONIA ASPIRATION 1243 0.0497
92 HALLUCINATION, AUDITORY 788 0.0495
93 PULMONARY FIBROSIS 948 0.0494
94 PARADOXICAL DRUG REACTION 181 0.0491
95 SINUS TACHYCARDIA 697 0.0490
96 FAILURE TO THRIVE 253 0.0487
97 NAIL DISORDER 426 0.0486
98 PSYCHOLOGICAL TRAUMA 417 0.0483
99 SYSTEMIC LUPUS ERYTHEMATOSUS 1698 0.0478
100 FEBRILE NEUTROPENIA 3168 0.0477
101 METABOLIC ENCEPHALOPATHY 143 0.0476
102 REBOUND ACID HYPERSECRETION 144 0.0476
103 BLOOD CHOLESTEROL INCREASED 2213 0.0474
104 CEREBRAL ATROPHY 185 0.0464
105 AKATHISIA 633 0.0463
106 RASH VESICULAR 223 0.0461
107 NIGHT SWEATS 1477 0.0458
108 ANXIETY DISORDER 153 0.0458
109 BONE LESION 165 0.0457
110 SUICIDE ATTEMPT 2686 0.0443
111 OSTEOARTHRITIS 1875 0.0442
112 MENTAL STATUS CHANGES 1226 0.0441
113 SALIVARY HYPERSECRETION 441 0.0440
114 RED CELL DISTRIBUTION WIDTH INCREASED 183 0.0440
115 COMPLETED SUICIDE 3668 0.0440
116 DELUSION 683 0.0439
117 DISSOCIATION 335 0.0437
118 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 223 0.0435
119 ATAXIA 511 0.0430
120 LOWER RESPIRATORY TRACT INFECTION 1954 0.0429
121 AGITATION 3118 0.0424
122 TACHYPHRENIA 146 0.0421
123 RESPIRATORY ACIDOSIS 165 0.0419
124 DRUG ABUSE 3470 0.0416
125 BREAST CANCER STAGE II 346 0.0415
126 STOMATITIS 2522 0.0415
127 HALLUCINATIONS, MIXED 174 0.0413
128 HOMICIDAL IDEATION 166 0.0409
129 BIPOLAR DISORDER 444 0.0408
130 HYPERNATRAEMIA 202 0.0405
131 IMPULSIVE BEHAVIOUR 152 0.0405
132 PARANOIA 698 0.0404
133 MULTIPLE DRUG OVERDOSE 200 0.0403
134 COMMUNICATION DISORDER 154 0.0402
135 MANIA 658 0.0400
136 HYPERLIPIDAEMIA 476 0.0398
137 POISONING 499 0.0397
138 PRE-EXISTING CONDITION IMPROVED 247 0.0395
139 PULSELESS ELECTRICAL ACTIVITY 165 0.0394
140 COMA 1877 0.0394
141 RED BLOOD CELL SEDIMENTATION RATE INCREASED 435 0.0393
142 NEUTROPHIL COUNT INCREASED 401 0.0391
143 PSORIATIC ARTHROPATHY 1576 0.0388
144 FEELING OF DESPAIR 181 0.0388
145 DEPRESSED LEVEL OF CONSCIOUSNESS 1532 0.0387
146 LUPUS-LIKE SYNDROME 350 0.0386
147 SPINAL OSTEOARTHRITIS 338 0.0384
148 GRANULOCYTOPENIA 219 0.0384
149 FOOT DEFORMITY 425 0.0383
150 LEFT VENTRICULAR HYPERTROPHY 164 0.0383
151 RESTLESSNESS 1402 0.0383
152 AFFECTIVE DISORDER 300 0.0381
153 MYOCLONUS 452 0.0379
154 OBSESSIVE-COMPULSIVE DISORDER 304 0.0378
155 INCONTINENCE 400 0.0378
156 JOINT DISLOCATION 397 0.0375
157 DROOLING 258 0.0373
158 SUICIDAL BEHAVIOUR 155 0.0372
159 CONTRAINDICATED PRODUCT ADMINISTERED 1111 0.0367
160 POST-TRAUMATIC STRESS DISORDER 245 0.0365
161 SUSPECTED SUICIDE 171 0.0365
162 INTERVERTEBRAL DISC DEGENERATION 337 0.0364
163 UNRESPONSIVE TO STIMULI 939 0.0363
164 MUSCULOSKELETAL PAIN 1906 0.0363
165 BUNDLE BRANCH BLOCK RIGHT 167 0.0363
166 DYSTONIA 704 0.0363
167 DYSARTHRIA 1362 0.0361
168 POLYDIPSIA 143 0.0361
169 GAIT INABILITY 1195 0.0357
170 CONFUSIONAL STATE 5762 0.0356
171 WHEEZING 2106 0.0355
172 HYPOXIA 1250 0.0355
173 DYSLIPIDAEMIA 180 0.0354
174 HYPOTHERMIA 356 0.0351
175 MIOSIS 282 0.0351
176 BUNDLE BRANCH BLOCK LEFT 149 0.0351
177 INFUSION RELATED REACTION 2322 0.0350
178 BLOOD PROLACTIN INCREASED 165 0.0350
179 AGGRESSION 1744 0.0348
180 ASPIRATION 381 0.0348
181 REFUSAL OF TREATMENT BY PATIENT 227 0.0347
182 OEDEMA 1880 0.0346
183 ACUTE RESPIRATORY FAILURE 666 0.0346
184 PARTIAL SEIZURES 181 0.0345
185 ARTHROPATHY 1920 0.0345
186 TRICUSPID VALVE INCOMPETENCE 274 0.0345
187 HIP ARTHROPLASTY 527 0.0344
188 HAIR DISORDER 282 0.0342
189 LEUKOCYTOSIS 615 0.0339
190 URINE ABNORMALITY 154 0.0338
191 ELECTROCARDIOGRAM QT PROLONGED 1217 0.0338
192 DRUG TOLERANCE 171 0.0338
193 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 347 0.0338
194 DYSPHEMIA 148 0.0337
195 DISCOMFORT 2043 0.0335
196 BLISTER 1872 0.0333
197 INTENTIONAL OVERDOSE 2133 0.0332
198 INJURY 2333 0.0332
199 LUNG INFILTRATION 293 0.0331
200 BRAIN INJURY 331 0.0330
201 SLEEP APNOEA SYNDROME 628 0.0329
202 BLOOD MAGNESIUM DECREASED 283 0.0328
203 END STAGE RENAL DISEASE 597 0.0327
204 BEHAVIOUR DISORDER 177 0.0327
205 ROAD TRAFFIC ACCIDENT 1368 0.0327
206 PANIC REACTION 236 0.0327
207 HEPATIC ENZYME INCREASED 2228 0.0326
208 HAEMATOCRIT DECREASED 648 0.0326
209 HEPATIC CIRRHOSIS 614 0.0326
210 EXTRAPYRAMIDAL DISORDER 809 0.0325
211 MALNUTRITION 364 0.0325
212 POISONING DELIBERATE 307 0.0323
213 BLOOD PRESSURE SYSTOLIC INCREASED 631 0.0323
214 DISORIENTATION 1278 0.0322
215 PANIC ATTACK 1173 0.0322
216 ARTERIOSCLEROSIS CORONARY ARTERY 213 0.0321
217 ANXIETY 9118 0.0320
218 SOCIAL AVOIDANT BEHAVIOUR 185 0.0319
219 CLOSTRIDIUM DIFFICILE COLITIS 337 0.0318
220 APNOEA 247 0.0317
221 SLEEP DISORDER 2239 0.0317
222 BLOOD LACTIC ACID INCREASED 167 0.0317
223 LUNG DISORDER 1552 0.0316
224 BLOOD PRESSURE DIASTOLIC INCREASED 146 0.0316
225 HYPOVOLAEMIA 185 0.0316
226 DECUBITUS ULCER 257 0.0315
227 MITRAL VALVE INCOMPETENCE 356 0.0314
228 RENAL FAILURE CHRONIC 241 0.0313
229 GENERALISED TONIC-CLONIC SEIZURE 515 0.0311
230 SMALL INTESTINAL OBSTRUCTION 381 0.0309
231 INCOHERENT 200 0.0309
232 HALLUCINATION, VISUAL 650 0.0308
233 SCREAMING 196 0.0307
234 DYSKINESIA 1249 0.0307
235 FAECAL INCONTINENCE 147 0.0306
236 SUICIDAL IDEATION 2801 0.0306
237 PATHOLOGICAL FRACTURE 155 0.0305
238 AMNESIA 1984 0.0305
239 RESPIRATORY ARREST 840 0.0304
240 TORSADE DE POINTES 239 0.0304
241 TACHYCARDIA 2700 0.0304
242 MYOSITIS 272 0.0303
243 DRUG INTERACTION 4796 0.0302
244 MYDRIASIS 387 0.0301
245 CARDIOMEGALY 371 0.0301
246 BLOOD ALBUMIN DECREASED 239 0.0301
247 LEFT VENTRICULAR DYSFUNCTION 201 0.0300
248 PSYCHOMOTOR HYPERACTIVITY 497 0.0299
249 LYMPHOCYTE COUNT DECREASED 524 0.0296
250 ABNORMAL BEHAVIOUR 1169 0.0295
251 BLOOD PRESSURE DIASTOLIC DECREASED 217 0.0294
252 MICTURITION URGENCY 335 0.0293
253 GRAND MAL CONVULSION 270 0.0292
254 BACTERAEMIA 347 0.0292
255 RESTLESS LEGS SYNDROME 531 0.0292
256 HAIR COLOUR CHANGES 363 0.0291
257 ECONOMIC PROBLEM 442 0.0291
258 BLOOD SODIUM DECREASED 548 0.0290
259 FAECALOMA 159 0.0290
260 CONTUSION 2790 0.0290
261 C-REACTIVE PROTEIN INCREASED 1051 0.0289
262 HYPONATRAEMIA 1622 0.0288
263 TENDERNESS 300 0.0288
264 DIVERTICULUM 204 0.0287
265 THERAPY NON-RESPONDER 1290 0.0287
266 EAR PAIN 556 0.0286
267 DRY MOUTH 2313 0.0285
268 HYPERTHERMIA 217 0.0284
269 TYPE 1 DIABETES MELLITUS 171 0.0284
270 HYPERTRANSAMINASAEMIA 197 0.0283
271 HAIR TEXTURE ABNORMAL 378 0.0282
272 ORAL PAIN 632 0.0282
273 PRESCRIBED UNDERDOSE 563 0.0282
274 URINARY INCONTINENCE 833 0.0281
275 BRAIN OEDEMA 355 0.0281
276 MUCOSAL INFLAMMATION 734 0.0280
277 HYPERVENTILATION 162 0.0279
278 HYPOKALAEMIA 1289 0.0279
279 DRUG TOXICITY 380 0.0279
280 HOSPICE CARE 275 0.0278
281 PROCTALGIA 179 0.0278
282 HYPOMAGNESAEMIA 385 0.0276
283 TROPONIN INCREASED 210 0.0276
284 HYPERTONIA 158 0.0276
285 ELECTROCARDIOGRAM ABNORMAL 216 0.0275
286 ENCEPHALOPATHY 672 0.0273
287 MUSCULOSKELETAL STIFFNESS 2394 0.0273
288 BODY TEMPERATURE DECREASED 269 0.0273
289 SOMNOLENCE 5501 0.0273
290 RENAL CYST 216 0.0272
291 MADAROSIS 314 0.0270
292 SINUSITIS 2772 0.0270
293 THINKING ABNORMAL 502 0.0269
294 MENTAL IMPAIRMENT 652 0.0269
295 BRUXISM 145 0.0269
296 MOBILITY DECREASED 1922 0.0267
297 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 458 0.0267
298 GENERAL PHYSICAL HEALTH DETERIORATION 3090 0.0267
299 GINGIVITIS 144 0.0267
300 GASTROOESOPHAGEAL REFLUX DISEASE 2147 0.0266
301 DEPRESSION 6067 0.0266
302 ORTHOSTATIC HYPOTENSION 462 0.0265
303 OBSTRUCTIVE AIRWAYS DISORDER 294 0.0264
304 TASTE DISORDER 536 0.0264
305 BODY TEMPERATURE INCREASED 539 0.0264
306 FLANK PAIN 247 0.0263
307 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1373 0.0263
308 WHITE BLOOD CELL COUNT INCREASED 1009 0.0263
309 FULL BLOOD COUNT ABNORMAL 278 0.0263
310 FEELING OF BODY TEMPERATURE CHANGE 154 0.0262
311 BLOOD CREATINE PHOSPHOKINASE INCREASED 752 0.0261
312 TOXICITY TO VARIOUS AGENTS 4404 0.0261
313 COLITIS ISCHAEMIC 176 0.0261
314 RESPIRATORY RATE INCREASED 231 0.0260
315 EMPHYSEMA 262 0.0259
316 MENTAL DISORDER 1128 0.0259
317 BLOOD PRESSURE FLUCTUATION 622 0.0259
318 ELECTROLYTE IMBALANCE 301 0.0259
319 TACHYPNOEA 351 0.0258
320 NOCTURIA 313 0.0258
321 IRON DEFICIENCY ANAEMIA 238 0.0258
322 HYPOPHAGIA 659 0.0258
323 SWELLING 2410 0.0257
324 WITHDRAWAL SYNDROME 1078 0.0256
325 COORDINATION ABNORMAL 358 0.0256
326 HALLUCINATION 1931 0.0256
327 DRUG LEVEL INCREASED 424 0.0256
328 HYPOKINESIA 371 0.0255
329 LIVER DISORDER 1127 0.0254
330 RED BLOOD CELL COUNT DECREASED 724 0.0253
331 SINUS BRADYCARDIA 244 0.0252
332 WEIGHT FLUCTUATION 264 0.0252
333 ENTERITIS 161 0.0251
334 RHABDOMYOLYSIS 1047 0.0251
335 DECREASED INTEREST 148 0.0251
336 DEHYDRATION 3338 0.0250
337 BRADYCARDIA 1326 0.0250
338 LETHARGY 1438 0.0250
339 GENERAL SYMPTOM 187 0.0249
340 CARDIO-RESPIRATORY ARREST 1040 0.0248
341 DENTAL CARIES 275 0.0248
342 INFLAMMATION 1283 0.0248
343 MIDDLE INSOMNIA 464 0.0248
344 MUSCLE SPASTICITY 305 0.0248
345 LACERATION 233 0.0248
346 COGNITIVE DISORDER 1156 0.0247
347 PROTHROMBIN TIME PROLONGED 148 0.0247
348 VENTRICULAR EXTRASYSTOLES 256 0.0246
349 KNEE ARTHROPLASTY 519 0.0246
350 ECCHYMOSIS 169 0.0246
351 ALTERED STATE OF CONSCIOUSNESS 534 0.0246
352 URINARY RETENTION 815 0.0244
353 TOOTH ABSCESS 248 0.0243
354 SUPRAVENTRICULAR TACHYCARDIA 233 0.0243
355 INSOMNIA 6474 0.0243
356 SOMNAMBULISM 159 0.0242
357 FEAR 651 0.0242
358 SPEECH DISORDER 1266 0.0241
359 BLOOD CALCIUM DECREASED 271 0.0241
360 EAR INFECTION 641 0.0241
361 CHRONIC KIDNEY DISEASE 1830 0.0241
362 ORAL CANDIDIASIS 317 0.0240
363 DRUG USE DISORDER 202 0.0240
364 ARTERIOSCLEROSIS 226 0.0240
365 BACK INJURY 261 0.0240
366 EATING DISORDER 511 0.0240
367 OSTEOPENIA 364 0.0240
368 PSYCHIATRIC SYMPTOM 177 0.0240
369 RESPIRATORY DISTRESS 659 0.0239
370 PAROSMIA 180 0.0238
371 BONE DISORDER 434 0.0238
372 JOINT SWELLING 2869 0.0237
373 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 403 0.0237
374 RESPIRATORY FAILURE 1727 0.0237
375 BACK DISORDER 385 0.0237
376 SKIN LACERATION 257 0.0236
377 HEPATIC STEATOSIS 440 0.0236
378 POOR QUALITY SLEEP 508 0.0236
379 CONVULSION 1348 0.0235
380 DYSPEPSIA 2319 0.0235
381 SEIZURE 2716 0.0235
382 HYPOAESTHESIA 3511 0.0234
383 PLEURAL EFFUSION 1425 0.0234
384 RIB FRACTURE 480 0.0233
385 GASTROINTESTINAL DISORDER 2090 0.0233
386 FEELING JITTERY 444 0.0233
387 APHASIA 701 0.0232
388 CHEST PAIN 4299 0.0232
389 AFFECT LABILITY 223 0.0231
390 ACIDOSIS 177 0.0231
391 MIGRAINE 2208 0.0231
392 MYOCARDITIS 265 0.0231
393 TREMOR 3826 0.0230
394 LIVER FUNCTION TEST ABNORMAL 670 0.0230
395 CRYING 836 0.0230
396 HIATUS HERNIA 297 0.0229
397 OSTEOPOROSIS 941 0.0229
398 DISABILITY 452 0.0228
399 BLOOD POTASSIUM DECREASED 685 0.0228
400 DRUG SCREEN POSITIVE 180 0.0228
401 DRUG INTOLERANCE 2197 0.0227
402 HAEMORRHOIDS 443 0.0227
403 RESPIRATORY DISORDER 679 0.0227
404 PREGNANCY 454 0.0227
405 GROIN PAIN 199 0.0226
406 OESOPHAGITIS 247 0.0226
407 URINE OUTPUT DECREASED 197 0.0225
408 RECTAL HAEMORRHAGE 968 0.0225
409 IMPAIRED GASTRIC EMPTYING 307 0.0225
410 POOR VENOUS ACCESS 232 0.0224
411 DECREASED APPETITE 5202 0.0224
412 RENAL FAILURE ACUTE 950 0.0224
413 NERVOUSNESS 1168 0.0223
414 ILL-DEFINED DISORDER 1356 0.0223
415 HEAD INJURY 704 0.0222
416 UPPER-AIRWAY COUGH SYNDROME 183 0.0222
417 HYPERTENSION 4688 0.0221
418 ILEUS 275 0.0221
419 TARDIVE DYSKINESIA 624 0.0221
420 WEIGHT INCREASED 4951 0.0221
421 GALLBLADDER DISORDER 394 0.0221
422 JOINT STIFFNESS 579 0.0220
423 ABDOMINAL DISCOMFORT 3679 0.0219
424 CARDIAC ARREST 1810 0.0219
425 PULMONARY CONGESTION 289 0.0219
426 HYDRONEPHROSIS 164 0.0219
427 SENSORY LOSS 176 0.0218
428 LYMPHOEDEMA 151 0.0218
429 ANHEDONIA 573 0.0218
430 FREQUENT BOWEL MOVEMENTS 589 0.0218
431 OEDEMA PERIPHERAL 2647 0.0217
432 SINUS CONGESTION 293 0.0217
433 APATHY 316 0.0216
434 HYPERSOMNIA 621 0.0216
435 MEMORY IMPAIRMENT 2966 0.0216
436 TONGUE DISORDER 156 0.0215
437 ATRIAL FLUTTER 172 0.0215
438 FEELING DRUNK 160 0.0215
439 VITAMIN D DECREASED 184 0.0215
440 EPILEPSY 653 0.0213
441 BLOOD COUNT ABNORMAL 323 0.0213
442 PRODUCTIVE COUGH 1015 0.0212
443 BLOOD ALKALINE PHOSPHATASE INCREASED 527 0.0212
444 MUSCLE TWITCHING 489 0.0212
445 UPPER GASTROINTESTINAL HAEMORRHAGE 356 0.0211
446 METABOLIC ACIDOSIS 675 0.0211
447 OXYGEN SATURATION DECREASED 1186 0.0211
448 MATERNAL EXPOSURE DURING PREGNANCY 1877 0.0210
449 ANAL INCONTINENCE 189 0.0210
450 ORAL DISORDER 154 0.0210
451 MUSCULOSKELETAL CHEST PAIN 325 0.0210
452 MUSCLE DISORDER 170 0.0210
453 HYPERGLYCAEMIA 764 0.0209
454 PANCREATITIS 1107 0.0209
455 FRUSTRATION TOLERANCE DECREASED 169 0.0209
456 HYPOTENSION 4191 0.0209
457 BLOOD TRIGLYCERIDES INCREASED 369 0.0209
458 ALOPECIA 4099 0.0209
459 PERIPHERAL SWELLING 3215 0.0208
460 METASTASES TO CENTRAL NERVOUS SYSTEM 269 0.0208
461 BLOOD UREA INCREASED 349 0.0208
462 LOWER GASTROINTESTINAL HAEMORRHAGE 154 0.0208
463 PULMONARY MASS 310 0.0208
464 IMPAIRED DRIVING ABILITY 236 0.0207
465 LEUKOPENIA 1038 0.0207
466 INTENTIONAL PRODUCT USE ISSUE 1816 0.0207
467 PULMONARY HYPERTENSION 431 0.0207
468 BALANCE DISORDER 1788 0.0207
469 HEART RATE DECREASED 726 0.0207
470 GASTRITIS 544 0.0207
471 THERAPEUTIC PRODUCT EFFECT DECREASED 925 0.0206
472 RHEUMATOID ARTHRITIS 2341 0.0206
473 RENAL TUBULAR NECROSIS 202 0.0206
474 INITIAL INSOMNIA 211 0.0205
475 CANDIDA INFECTION 347 0.0205
476 HYPOTONIA 205 0.0205
477 LIGAMENT SPRAIN 203 0.0205
478 CARDIAC MURMUR 177 0.0204
479 NECK PAIN 1143 0.0204
480 LOSS OF CONSCIOUSNESS 2620 0.0204
481 DYSPHAGIA 1935 0.0204
482 TREATMENT NONCOMPLIANCE 1115 0.0204
483 OSTEOMYELITIS 369 0.0204
484 CONSTIPATION 4434 0.0203
485 BLADDER DISORDER 201 0.0202
486 HAEMODYNAMIC INSTABILITY 154 0.0202
487 DIABETES MELLITUS 1540 0.0202
488 ANOREXIA 260 0.0202
489 CARDIOMYOPATHY 298 0.0201
490 HEPATIC ENCEPHALOPATHY 188 0.0201
491 HEART RATE IRREGULAR 454 0.0201
492 FACIAL PAIN 179 0.0200
493 CELLULITIS 1007 0.0200
494 ASTHMA 2252 0.0199
495 FALL 6627 0.0199
496 INTERVERTEBRAL DISC PROTRUSION 435 0.0199
497 HYPOPHOSPHATAEMIA 147 0.0199
498 VENTRICULAR TACHYCARDIA 328 0.0198
499 HEART RATE INCREASED 1967 0.0198
500 SPINAL COMPRESSION FRACTURE 164 0.0198
501 SPUTUM DISCOLOURED 188 0.0198
502 MOVEMENT DISORDER 636 0.0198
503 EMOTIONAL DISORDER 610 0.0198
504 ABDOMINAL PAIN 4600 0.0198
505 DISTURBANCE IN ATTENTION 1064 0.0197
506 DYSURIA 726 0.0197
507 ABDOMINAL PAIN UPPER 4060 0.0197
508 PERSONALITY CHANGE 183 0.0197
509 NEUROPATHY PERIPHERAL 1873 0.0197
510 TRANSFUSION 206 0.0196
511 METASTASES TO LIVER 345 0.0196
512 ACUTE RESPIRATORY DISTRESS SYNDROME 347 0.0196
513 ASPARTATE AMINOTRANSFERASE INCREASED 1038 0.0195
514 ASTHENIA 7347 0.0195
515 CONCUSSION 151 0.0195
516 TOOTH FRACTURE 215 0.0195
517 CYTOKINE RELEASE SYNDROME 391 0.0195
518 DEMENTIA 544 0.0194
519 NEUTROPHIL COUNT DECREASED 793 0.0194
520 NERVE INJURY 216 0.0194
521 PELVIC FRACTURE 151 0.0194
522 BRONCHITIS 1435 0.0194
523 ACUTE KIDNEY INJURY 2959 0.0193
524 CYANOSIS 304 0.0193
525 MULTIPLE ALLERGIES 151 0.0192
526 TOOTHACHE 348 0.0192
527 MUSCULAR WEAKNESS 2183 0.0192
528 CARPAL TUNNEL SYNDROME 269 0.0192
529 DEEP VEIN THROMBOSIS 1248 0.0192
530 PNEUMONIA 6212 0.0192
531 PARAESTHESIA 3015 0.0191
532 PANCYTOPENIA 1071 0.0191
533 CHOLECYSTITIS 228 0.0191
534 SPLENOMEGALY 224 0.0191
535 HAEMOGLOBIN DECREASED 1963 0.0191
536 GAIT DISTURBANCE 3658 0.0191
537 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 916 0.0191
538 HEPATOMEGALY 187 0.0190
539 HYPERAESTHESIA 156 0.0190
540 ANGER 642 0.0190
541 BLOOD PRESSURE INCREASED 2902 0.0190
542 VOMITING 8921 0.0190
543 DEPRESSED MOOD 1003 0.0190
544 WEIGHT DECREASED 5293 0.0189
545 GLOMERULAR FILTRATION RATE DECREASED 233 0.0189
546 URINARY TRACT INFECTION 3231 0.0189
547 EUPHORIC MOOD 194 0.0189
548 CONDITION AGGRAVATED 5752 0.0189
549 UPPER RESPIRATORY TRACT INFECTION 873 0.0189
550 NEURALGIA 459 0.0189
551 RENAL FAILURE 2499 0.0188
552 DECREASED ACTIVITY 203 0.0188
553 DIABETES MELLITUS INADEQUATE CONTROL 333 0.0188
554 MUSCULOSKELETAL DISCOMFORT 323 0.0187
555 PERICARDIAL EFFUSION 433 0.0187
556 INFECTION 2710 0.0187
557 MUSCLE TIGHTNESS 303 0.0187
558 POLLAKIURIA 780 0.0187
559 TOOTH INFECTION 246 0.0186
560 NASOPHARYNGITIS 3434 0.0186
561 MOOD ALTERED 508 0.0186
562 PYREXIA 6434 0.0186
563 INTERNATIONAL NORMALISED RATIO INCREASED 530 0.0186
564 INCREASED APPETITE 355 0.0186
565 TOXIC EPIDERMAL NECROLYSIS 282 0.0186
566 APHTHOUS ULCER 144 0.0185
567 ASCITES 545 0.0185
568 IRRITABILITY 1110 0.0184
569 MASS 257 0.0184
570 HYPERHIDROSIS 2362 0.0183
571 HYPOAESTHESIA ORAL 276 0.0183
572 ALANINE AMINOTRANSFERASE INCREASED 1123 0.0183
573 SEPSIS 2040 0.0183
574 NIGHTMARE 631 0.0182
575 PALLOR 496 0.0182
576 FULL BLOOD COUNT DECREASED 366 0.0181
577 MOTOR DYSFUNCTION 185 0.0181
578 INCREASED TENDENCY TO BRUISE 167 0.0181
579 LABORATORY TEST ABNORMAL 533 0.0180
580 BLOOD IRON DECREASED 214 0.0180
581 HEMIPARESIS 305 0.0180
582 SUBDURAL HAEMATOMA 257 0.0179
583 SEPTIC SHOCK 781 0.0179
584 SLUGGISHNESS 183 0.0179
585 FATIGUE 13959 0.0179
586 CENTRAL NERVOUS SYSTEM LESION 246 0.0179
587 PLATELET COUNT DECREASED 1907 0.0179
588 MOOD SWINGS 569 0.0178
589 PERIPHERAL COLDNESS 245 0.0178
590 DRUG WITHDRAWAL SYNDROME 1565 0.0178
591 COLITIS 676 0.0178
592 EJECTION FRACTION DECREASED 277 0.0178
593 MUSCLE SPASMS 3270 0.0178
594 HYPERCALCAEMIA 220 0.0178
595 PAIN IN JAW 504 0.0178
596 ACTIVITIES OF DAILY LIVING IMPAIRED 352 0.0178
597 PULMONARY OEDEMA 796 0.0178
598 PULMONARY EMBOLISM 1686 0.0177
599 METASTASES TO BONE 291 0.0177
600 WHITE BLOOD CELL COUNT DECREASED 1920 0.0177
601 UROSEPSIS 163 0.0177
602 MULTI-ORGAN FAILURE 305 0.0176
603 CYSTITIS 561 0.0176
604 GASTROENTERITIS 257 0.0176
605 PARALYSIS 252 0.0176
606 PLATELET COUNT INCREASED 228 0.0175
607 POLYURIA 143 0.0174
608 HYPERKALAEMIA 611 0.0174
609 CHOLELITHIASIS 571 0.0174
610 NAUSEA 13780 0.0174
611 RENAL INJURY 517 0.0174
612 SEXUAL DYSFUNCTION 204 0.0174
613 SUDDEN DEATH 184 0.0174
614 ADRENAL INSUFFICIENCY 211 0.0174
615 COAGULOPATHY 289 0.0173
616 DYSPNOEA EXERTIONAL 652 0.0173
617 MYOCARDIAL ISCHAEMIA 197 0.0173
618 BLOOD LACTATE DEHYDROGENASE INCREASED 274 0.0173
619 BEDRIDDEN 227 0.0173
620 TOOTH DISORDER 384 0.0173
621 HYPOTHYROIDISM 551 0.0172
622 BLOOD BILIRUBIN INCREASED 466 0.0172
623 EOSINOPHILIA 302 0.0172
624 URTICARIA 2886 0.0172
625 TINNITUS 790 0.0172
626 BONE PAIN 1007 0.0172
627 SPINAL DISORDER 162 0.0171
628 PHARYNGITIS 212 0.0171
629 ANAEMIA 3258 0.0171
630 PNEUMOTHORAX 270 0.0170
631 DYSPNOEA 9576 0.0169
632 DIZZINESS 8426 0.0169
633 GENERALISED OEDEMA 209 0.0169
634 FEEDING DISORDER 342 0.0168
635 ARTHRITIS 1326 0.0168
636 METASTASES TO LUNG 194 0.0168
637 PETECHIAE 175 0.0168
638 CLOSTRIDIUM DIFFICILE INFECTION 366 0.0168
639 INTESTINAL PERFORATION 188 0.0167
640 THYROID DISORDER 258 0.0167
641 HAEMATEMESIS 424 0.0167
642 MEDICATION ERROR 926 0.0166
643 DIARRHOEA 10751 0.0166
644 ATRIAL FIBRILLATION 1621 0.0166
645 BACK PAIN 3865 0.0166
646 QUALITY OF LIFE DECREASED 223 0.0166
647 BLOOD CREATININE INCREASED 1085 0.0166
648 SEASONAL ALLERGY 235 0.0166
649 IMPAIRED QUALITY OF LIFE 238 0.0165
650 VITAMIN D DEFICIENCY 161 0.0165
651 SYNCOPE 1649 0.0165
652 THROMBOCYTOPENIA 1843 0.0165
653 DRUG LEVEL DECREASED 167 0.0164
654 THIRST 293 0.0164
655 VENTRICULAR FIBRILLATION 182 0.0164
656 LYMPHADENOPATHY 580 0.0164
657 TUMOUR LYSIS SYNDROME 144 0.0164
658 AGRANULOCYTOSIS 304 0.0163
659 PALPITATIONS 1895 0.0162
660 FEELING HOT 990 0.0161
661 PNEUMONITIS 439 0.0161
662 HAEMOPTYSIS 448 0.0160
663 TREATMENT FAILURE 1330 0.0160
664 CORONARY ARTERY DISEASE 483 0.0159
665 FEELING COLD 444 0.0159
666 DRY THROAT 162 0.0159
667 NEOPLASM PROGRESSION 554 0.0159
668 SINUS DISORDER 315 0.0159
669 HIP FRACTURE 510 0.0158
670 NERVE COMPRESSION 146 0.0158
671 FLUID RETENTION 804 0.0158
672 LIVER FUNCTION TEST INCREASED 339 0.0158
673 DIPLOPIA 410 0.0158
674 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 865 0.0157
675 DYSPHONIA 921 0.0157
676 ANKLE FRACTURE 243 0.0157
677 EXPOSURE DURING PREGNANCY 975 0.0157
678 EAR DISCOMFORT 161 0.0157
679 ABDOMINAL DISTENSION 1634 0.0156
680 ABNORMAL DREAMS 432 0.0156
681 DIVERTICULITIS 433 0.0156
682 PRESYNCOPE 379 0.0156
683 NO THERAPEUTIC RESPONSE 190 0.0156
684 TUBULOINTERSTITIAL NEPHRITIS 292 0.0156
685 HAEMATOMA 403 0.0155
686 FOOT FRACTURE 294 0.0155
687 CIRCULATORY COLLAPSE 264 0.0155
688 BLOOD PRESSURE ABNORMAL 307 0.0154
689 PARAESTHESIA ORAL 222 0.0154
690 NERVOUS SYSTEM DISORDER 480 0.0154
691 PLASMA CELL MYELOMA 599 0.0153
692 LIMB INJURY 416 0.0153
693 OVERDOSE 3300 0.0153
694 STAPHYLOCOCCAL INFECTION 504 0.0153
695 ROTATOR CUFF SYNDROME 196 0.0152
696 LUNG INFECTION 237 0.0152
697 CHILLS 1788 0.0152
698 BODY HEIGHT DECREASED 163 0.0152
699 TRANSIENT ISCHAEMIC ATTACK 513 0.0152
700 CARDIOGENIC SHOCK 218 0.0152
701 FEELING ABNORMAL 3636 0.0152
702 BLOOD POTASSIUM INCREASED 246 0.0151
703 RETCHING 323 0.0151
704 PANCREATITIS ACUTE 340 0.0151
705 RESPIRATORY TRACT CONGESTION 240 0.0151
706 SENSORY DISTURBANCE 242 0.0151
707 ARRHYTHMIA 714 0.0151
708 CHOKING 294 0.0151
709 DISEASE PROGRESSION 1778 0.0150
710 PAIN IN EXTREMITY 4416 0.0150
711 FLUID OVERLOAD 218 0.0150
712 BLOOD PRESSURE DECREASED 995 0.0150
713 NEUTROPENIA 2032 0.0149
714 DEVICE RELATED INFECTION 230 0.0149
715 DRUG-INDUCED LIVER INJURY 468 0.0149
716 DERMATITIS CONTACT 170 0.0149
717 LOCAL SWELLING 260 0.0149
718 GASTROENTERITIS VIRAL 269 0.0149
719 FISTULA 167 0.0148
720 CHEST DISCOMFORT 1521 0.0148
721 ERECTILE DYSFUNCTION 380 0.0148
722 PHOTOPHOBIA 278 0.0148
723 ARTHRALGIA 6142 0.0148
724 SKIN LESION 404 0.0147
725 ACCIDENTAL OVERDOSE 538 0.0147
726 WRIST FRACTURE 176 0.0147
727 VIRAL INFECTION 488 0.0146
728 PHOTOSENSITIVITY REACTION 242 0.0146
729 INTESTINAL OBSTRUCTION 552 0.0146
730 DIZZINESS POSTURAL 142 0.0146
731 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1041 0.0146
732 OVARIAN CYST 146 0.0146
733 SWOLLEN TONGUE 456 0.0146
734 PAIN 8966 0.0146
735 EPISTAXIS 1090 0.0146
736 VERTIGO 888 0.0146
737 INFUSION SITE PAIN 187 0.0145
738 POST PROCEDURAL COMPLICATION 278 0.0145
739 SKIN ULCER 374 0.0145
740 HEAD DISCOMFORT 256 0.0144
741 NEOPLASM 166 0.0144
742 INTENTIONAL PRODUCT MISUSE 1264 0.0144
743 CARDIAC FAILURE CONGESTIVE 1157 0.0144
744 OROPHARYNGEAL PAIN 1332 0.0144
745 HYPOCALCAEMIA 272 0.0144
746 HEADACHE 8995 0.0143
747 MALAISE 6291 0.0143
748 FUNGAL INFECTION 478 0.0143
749 BLOOD URINE PRESENT 272 0.0143
750 COLD SWEAT 252 0.0143
751 SECRETION DISCHARGE 179 0.0143
752 ADVERSE DRUG REACTION 1279 0.0142
753 GAMMA-GLUTAMYLTRANSFERASE INCREASED 314 0.0142
754 HYPERSENSITIVITY 2628 0.0141
755 CORONARY ARTERY OCCLUSION 194 0.0141
756 LACTIC ACIDOSIS 457 0.0141
757 OSTEONECROSIS OF JAW 349 0.0141
758 GASTROINTESTINAL PAIN 155 0.0141
759 HERPES ZOSTER 808 0.0140
760 ABSCESS 223 0.0140
761 PHARYNGITIS STREPTOCOCCAL 151 0.0139
762 PRODUCT PRESCRIBING ERROR 332 0.0139
763 RESPIRATORY TRACT INFECTION 360 0.0138
764 VISION BLURRED 1895 0.0138
765 LIMB DISCOMFORT 427 0.0138
766 HEPATIC FAILURE 415 0.0138
767 MOUTH ULCERATION 290 0.0137
768 COUGH 3859 0.0137
769 MALIGNANT NEOPLASM PROGRESSION 1406 0.0137
770 BACTERIAL INFECTION 256 0.0137
771 ANGINA PECTORIS 392 0.0137
772 CHOLECYSTECTOMY 156 0.0136
773 BREAST PAIN 144 0.0135
774 NODULE 176 0.0135
775 SKIN INFECTION 151 0.0134
776 MUSCLE ATROPHY 170 0.0134
777 ULCER 213 0.0134
778 STEVENS-JOHNSON SYNDROME 297 0.0133
779 DYSSTASIA 390 0.0133
780 FLATULENCE 756 0.0133
781 THROAT TIGHTNESS 360 0.0133
782 HOT FLUSH 1003 0.0133
783 RASH PRURITIC 721 0.0133
784 ABASIA 327 0.0132
785 LOCALISED INFECTION 320 0.0132
786 RASH MACULO-PAPULAR 294 0.0132
787 SKIN DISCOLOURATION 607 0.0132
788 KIDNEY INFECTION 259 0.0132
789 HAEMATURIA 451 0.0132
790 SCAR 225 0.0131
791 CYST 163 0.0131
792 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 306 0.0131
793 HEPATOTOXICITY 292 0.0131
794 GASTROINTESTINAL HAEMORRHAGE 1093 0.0131
795 RHINORRHOEA 844 0.0130
796 ABDOMINAL PAIN LOWER 330 0.0130
797 SHOCK 300 0.0130
798 NEPHROLITHIASIS 597 0.0130
799 FAECES DISCOLOURED 282 0.0130
800 RASH 5667 0.0130
801 JOINT INJURY 277 0.0130
802 IMPAIRED WORK ABILITY 277 0.0129
803 INTENTIONAL DRUG MISUSE 269 0.0129
804 EYE INFECTION 145 0.0128
805 GASTRIC ULCER 244 0.0128
806 NASAL CONGESTION 750 0.0127
807 PRODUCT USE IN UNAPPROVED INDICATION 3141 0.0127
808 HAEMATOCHEZIA 699 0.0127
809 PRODUCT USE ISSUE 2375 0.0126
810 INFLUENZA 1407 0.0126
811 NEUROTOXICITY 221 0.0126
812 PHARYNGEAL OEDEMA 194 0.0126
813 ORAL HERPES 244 0.0125
814 UPPER LIMB FRACTURE 249 0.0125
815 GINGIVAL BLEEDING 170 0.0124
816 DIABETIC KETOACIDOSIS 299 0.0124
817 SWELLING FACE 807 0.0124
818 MYALGIA 2107 0.0124
819 ORAL DISCOMFORT 172 0.0124
820 THERAPY PARTIAL RESPONDER 193 0.0124
821 VISUAL IMPAIRMENT 1531 0.0123
822 IMMUNODEFICIENCY 184 0.0123
823 MELAENA 271 0.0123
824 ACUTE MYOCARDIAL INFARCTION 363 0.0123
825 DYSGEUSIA 914 0.0123
826 SPINAL FRACTURE 246 0.0123
827 PELVIC PAIN 223 0.0123
828 OFF LABEL USE 10744 0.0123
829 ACUTE MYELOID LEUKAEMIA 191 0.0122
830 BRAIN FOG 192 0.0122
831 LACRIMATION INCREASED 370 0.0122
832 CATARACT 728 0.0122
833 TOOTH EXTRACTION 152 0.0122
834 ERUCTATION 236 0.0122
835 HYPOGLYCAEMIA 588 0.0121
836 TRANSAMINASES INCREASED 268 0.0120
837 DERMATITIS 252 0.0120
838 APHONIA 167 0.0120
839 SARS-COV-2 TEST POSITIVE 158 0.0120
840 UNEVALUABLE EVENT 905 0.0119
841 THERAPEUTIC RESPONSE UNEXPECTED 536 0.0119
842 THROAT IRRITATION 533 0.0119
843 INFLUENZA LIKE ILLNESS 977 0.0119
844 BASAL CELL CARCINOMA 185 0.0118
845 EYE PAIN 666 0.0118
846 HEPATITIS 302 0.0118
847 CONJUNCTIVITIS 217 0.0117
848 GASTRIC DISORDER 400 0.0116
849 EMOTIONAL DISTRESS 1407 0.0116
850 COLITIS ULCERATIVE 519 0.0116
851 CHROMATURIA 262 0.0116
852 HUNGER 160 0.0115
853 ADVERSE EVENT 1057 0.0115
854 DISSEMINATED INTRAVASCULAR COAGULATION 161 0.0114
855 BRONCHOSPASM 163 0.0114
856 DRY EYE 569 0.0114
857 JAUNDICE 306 0.0114
858 PHARMACEUTICAL PRODUCT COMPLAINT 295 0.0113
859 PRURITUS 4349 0.0113
860 FLUSHING 1146 0.0113
861 BURNING SENSATION 790 0.0113
862 TENDONITIS 174 0.0112
863 UNDERDOSE 816 0.0112
864 BLOOD TEST ABNORMAL 157 0.0112
865 RASH GENERALISED 285 0.0110
866 IMMUNE SYSTEM DISORDER 145 0.0110
867 MULTIPLE ORGAN DYSFUNCTION SYNDROME 310 0.0109
868 FRACTURE 207 0.0109
869 GOUT 196 0.0109
870 PRODUCT SUBSTITUTION ISSUE 628 0.0109
871 RENAL IMPAIRMENT 912 0.0108
872 TOOTH LOSS 225 0.0108
873 FACE OEDEMA 182 0.0108
874 HERNIA 206 0.0106
875 PRURITUS GENERALISED 230 0.0106
876 ACUTE HEPATIC FAILURE 145 0.0106
877 CARDIAC FAILURE 841 0.0105
878 CEREBRAL HAEMORRHAGE 373 0.0104
879 GLAUCOMA 200 0.0104
880 THROMBOSIS 834 0.0104
881 MUSCULOSKELETAL DISORDER 197 0.0103
882 WRONG TECHNIQUE IN DRUG USAGE PROCESS 373 0.0103
883 LIP SWELLING 340 0.0102
884 THERAPEUTIC RESPONSE DECREASED 618 0.0102
885 PULMONARY ARTERIAL HYPERTENSION 147 0.0101
886 HAEMORRHAGE INTRACRANIAL 148 0.0099
887 SKIN DISORDER 325 0.0097
888 BONE MARROW FAILURE 197 0.0097
889 DRUG DEPENDENCE 1556 0.0097
890 DRUG INEFFECTIVE 12687 0.0096
891 INSURANCE ISSUE 147 0.0096
892 RENAL DISORDER 444 0.0095
893 HOSPITALISATION 1445 0.0094
894 RASH ERYTHEMATOUS 448 0.0094
895 SKIN FISSURES 183 0.0094
896 MULTIPLE FRACTURES 153 0.0093
897 ANAPHYLACTIC REACTION 514 0.0093
898 DRUG EFFECT DECREASED 499 0.0093
899 AGEUSIA 231 0.0093
900 LUNG NEOPLASM MALIGNANT 379 0.0092
901 PRODUCT PHYSICAL ISSUE 185 0.0092
902 CEREBROVASCULAR ACCIDENT 1553 0.0092
903 CARDIAC DISORDER 855 0.0091
904 CEREBRAL INFARCTION 223 0.0091
905 PRODUCT ADMINISTRATION ERROR 184 0.0091
906 PROCEDURAL PAIN 250 0.0090
907 ILLNESS 927 0.0090
908 VISUAL ACUITY REDUCED 298 0.0090
909 RASH MACULAR 313 0.0089
910 DEAFNESS 234 0.0089
911 HAEMORRHAGE 922 0.0088
912 MYOCARDIAL INFARCTION 1537 0.0088
913 RASH PAPULAR 196 0.0087
914 EYE SWELLING 325 0.0087
915 SURGERY 512 0.0087
916 DRUG ADMINISTRATION ERROR 268 0.0087
917 PROTEINURIA 164 0.0086
918 ERYTHEMA 1712 0.0083
919 PREMATURE BABY 250 0.0083
920 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 590 0.0083
921 DRUG PRESCRIBING ERROR 159 0.0083
922 MULTIPLE SCLEROSIS RELAPSE 567 0.0083
923 EYE DISORDER 272 0.0083
924 PRODUCT QUALITY ISSUE 1104 0.0081
925 BLOOD GLUCOSE DECREASED 386 0.0080
926 THERAPY CESSATION 412 0.0080
927 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 206 0.0080
928 INTENTIONAL DOSE OMISSION 228 0.0080
929 DEATH 6867 0.0080
930 CHOLESTASIS 153 0.0080
931 PRODUCT DOSE OMISSION 518 0.0079
932 FEMUR FRACTURE 241 0.0078
933 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1388 0.0077
934 ANGIOEDEMA 339 0.0077
935 COVID-19 1330 0.0076
936 SKIN CANCER 162 0.0075
937 DRUG RESISTANCE 192 0.0075
938 DRUG DOSE OMISSION 1225 0.0074
939 MULTIPLE SCLEROSIS 351 0.0073
940 HYPOACUSIS 315 0.0073
941 FOETAL EXPOSURE DURING PREGNANCY 593 0.0073
942 DRY SKIN 972 0.0073
943 PRODUCT AVAILABILITY ISSUE 165 0.0072
944 SNEEZING 160 0.0071
945 EYE IRRITATION 410 0.0071
946 INTERSTITIAL LUNG DISEASE 338 0.0070
947 HEPATIC FUNCTION ABNORMAL 258 0.0069
948 OCULAR HYPERAEMIA 327 0.0069
949 BLOOD GLUCOSE INCREASED 1294 0.0069
950 OSTEONECROSIS 225 0.0068
951 BLINDNESS 277 0.0068
952 DRUG EFFECT INCOMPLETE 244 0.0067
953 THERAPY INTERRUPTED 479 0.0067
954 PSORIASIS 859 0.0066
955 NEOPLASM MALIGNANT 435 0.0065
956 DISEASE RECURRENCE 308 0.0065
957 THERAPEUTIC RESPONSE SHORTENED 211 0.0064
958 DRUG EXPOSURE DURING PREGNANCY 211 0.0062
959 PRODUCT DOSE OMISSION ISSUE 1781 0.0061
960 BONE DENSITY DECREASED 188 0.0060
961 SKIN EXFOLIATION 506 0.0060
962 INCORRECT DOSE ADMINISTERED 1359 0.0059
963 EYE PRURITUS 200 0.0059
964 GLYCOSYLATED HAEMOGLOBIN INCREASED 150 0.0059
965 ECZEMA 308 0.0059
966 INJECTION SITE MASS 215 0.0058
967 NEEDLE ISSUE 168 0.0058
968 PRODUCT DOSE OMISSION IN ERROR 163 0.0058
969 INCORRECT DRUG ADMINISTRATION DURATION 161 0.0057
970 VAGINAL HAEMORRHAGE 246 0.0057
971 PAIN OF SKIN 152 0.0056
972 INJECTION SITE BRUISING 427 0.0053
973 INJECTION SITE REACTION 350 0.0051
974 ACNE 383 0.0050
975 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 961 0.0047
976 ABORTION SPONTANEOUS 178 0.0044
977 EXPIRED PRODUCT ADMINISTERED 147 0.0044
978 INCORRECT ROUTE OF DRUG ADMINISTRATION 158 0.0044
979 INJECTION SITE ERYTHEMA 546 0.0044
980 INJECTION SITE PAIN 1349 0.0044
981 DEVICE DISLOCATION 190 0.0044
982 INJECTION SITE PRURITUS 292 0.0044
983 BREAST CANCER 394 0.0042
984 EXTRA DOSE ADMINISTERED 161 0.0040
985 INJECTION SITE HAEMORRHAGE 307 0.0038
986 INJECTION SITE SWELLING 292 0.0038
987 DEVICE ISSUE 313 0.0035
988 SKIN BURNING SENSATION 247 0.0034
989 NO ADVERSE EVENT 612 0.0034
990 DEVICE MALFUNCTION 205 0.0029
991 DEPENDENCE 145 0.0026
992 ACCIDENTAL EXPOSURE TO PRODUCT 204 0.0020
993 PRODUCT STORAGE ERROR 146 0.0017